-
Estimating the Proportion of Heart Failure Admissions Potentially Eligible for Hospital at Home J. Card. Fail. (IF 6.0) Pub Date : 2024-04-06 HUBERT B. HAYWOOD MD MBA, AUBREY JOLLY GRAHAM MD, DAVID CHERMAK MIE, ADITYA ACHANTA MD, JAVED BUTLER MD MPH MBA, GREGG C. FONAROW MD, STEPHEN J. GREENE MD
-
Early Ventricular Arrhythmia in Post-LVAD Patients: A Silent Bystander or a Foe? J. Card. Fail. (IF 6.0) Pub Date : 2024-04-04 Nima Moghaddam MD
-
Real-world walking behaviors are associated with early-stage heart failure: a Project Baseline Health Study J. Card. Fail. (IF 6.0) Pub Date : 2024-04-04 Sooyoon Shin PhD, Nathan Kowahl MS, Taylor Hansen PhD, Albee Y. Ling PhD, Poulami Barman MS, Nicholas Cauwenberghs PhD, Erin Rainaldi MS, Sarah Short MPH, Jessilyn Dunn PhD, Md Mobashir Hasan Shandhi PhD, Svati H. Shah MD MHS, Kenneth W. Mahaffey MD, Tatiana Kuznetsova MD PhD, Melissa A. Daubert MD, Pamela S. Douglas MD, Francois Haddad MD, Ritu Kapur PhD
-
Hospice in Heart Failure Is Visible, Yet Still Out of Reach for Many J. Card. Fail. (IF 6.0) Pub Date : 2024-03-28 KEISUKE KIDA MD PhD, SHINJI TOKI MS Pharm, YOKO KANAMITSU MD, TAISHI OKUNO MD
-
Growth Differentiation Factor-15 and Clinical Outcomes in Patients With Chronic Heart Failure J. Card. Fail. (IF 6.0) Pub Date : 2024-03-26 DIANE XAVIER de ÁVILA MD, ANGELO MICHELE di CANDIA MD, GUSTAVO RODOLFO MOREIRA MD, VICTORIA DEPES SCARAMUSSA MD, RENATO D. LOPES MD PhD, HUMBERTO VILLACORTA MD PhD
-
Functional Mitral Regurgitation and Heart Failure With Preserved Ejection Fraction: Clinical Implications and Management J. Card. Fail. (IF 6.0) Pub Date : 2024-03-22 Mauro Riccardi MD, Maja Cikes MD, Marianna Adamo MD, Matteo Pagnesi MD, Carlo Mario Lombardi MD, Scott David Solomon MD, Marco Metra MD, Riccardo Maria Inciardi MD PhD
-
Assessment of Temporary Warfarin Reversal in Patients With Left Ventricular Assist Devices: the KVAD Study* J. Card. Fail. (IF 6.0) Pub Date : 2024-03-21 KATELYN W. SYLVESTER PharmD, JESSICA GRANDONI PharmD, MEGAN RHOTEN PharmD, LARA COAKLEY FNP-BC, ERIN LYONS-MATIELLO PA-C MMSC, KATIE FRANKEL PA-C MS, BROOKE FORTIN BS, KATE JOLLEY BA, HAE SOO PARK BS, REVITAL Y. FREEDMAN PhD, MANDEEP R. MEHRA MD MSc, MICHAEL M. GIVERTZ MD, JEAN M. CONNORS MD.
-
Rates of Reproductive Counseling and Contraception Use in Patients with Heart Failure at a Tertiary Care Center J. Card. Fail. (IF 6.0) Pub Date : 2024-03-19 KRISTEN E. WONG MD, AMANDA K. VERMA MD
-
Pulmonary Artery Diastolic Pressure as a Surrogate for Pulmonary Capillary Wedge Pressure in Cardiogenic Shock J. Card. Fail. (IF 6.0) Pub Date : 2024-03-19 ALEXANDER I. PAPOLOS MD, BENJAMIN B. KENIGSBERG MD, NARAYANA SARMA V. SINGAM MD, DAVID D. BERG MD, JIANPING GUO MAS, ERIN A. BOHULA MD PhD, JASON N. KATZ MD, SEAN VAN DIEPEN MD, DAVID A. MORROW MD MPH, Critical Care Cardiology Trials Network Investigators
-
Guide to Lung-Protective Ventilation in Cardiac Patients J. Card. Fail. (IF 6.0) Pub Date : 2024-03-19 ANIKET S. RALI MD, LENA TRAN MD, ADITI BALAKRISHNA MD, MOURAD SENUSSI MD MS, NAVIN K. KAPUR MD, THOMAS METKUS MD, RYAN J. TEDFORD MD, JOANN LINDENFELD MD
-
Efficacy and Safety of Aficamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4 J. Card. Fail. (IF 6.0) Pub Date : 2024-03-15 AHMAD MASRI MD MS, MARK V. SHERRID MD, THEODORE P. ABRAHAM MD, LUBNA CHOUDHURY MD MRCPI, PABLO GARCIA-PAVIA MD PhD, CHRISTOPHER M. KRAMER MRCPI, ROBERTO BARRIALES-VILLA MD PhD, ANJALI T. OWENS MD, FLORIAN RADER MD, SHERIF F. NAGUEH MD, IACOPO OLIVOTTO MD, SARA SABERI MD, ALBREE TOWER-RADER MD, TIMOTHY C. WONG MD, CAROLINE J. COATS MD PhD, HUGH WATKINS MD PhD, MICHAEL A. FIFER MD, SCOTT D. SOLOMON MD
-
Racial Differences in Palliative Care Use in Heart Failure Decedents J. Card. Fail. (IF 6.0) Pub Date : 2024-03-15 Sarah H. Cross PhD MSW MPH, Neal W. Dickert MD PhD, Alanna A. Morris MD MSc, Jabeen Taj MD, Modele O. Ogunniyi MD MPH, Dio Kavalieratos PhD
-
The Pandemic That Never Left J. Card. Fail. (IF 6.0) Pub Date : 2024-03-15 ABDUL MANNAN KHAN MINHAS MD, MARAT FUDIM MD, DMITRY ABRAMOV MD
-
Pitfalls and Opportunities for the Growing Role of AI in Heart Failure J. Card. Fail. (IF 6.0) Pub Date : 2024-03-12 JAGPREET S. GREWAL MD, PARTHO P. SENGUPTA MD
-
Synergy, not Silos: The Intersection of Medical and Surgical Training in Advanced Heart Failure J. Card. Fail. (IF 6.0) Pub Date : 2024-03-07 JENNA SKOWRONSKI MD, ALEXANDER G. HAJDUCZOK MD, LAURA DICHIACCHIO MD PhD
-
Capturing the Evolving Landscape of Primary Graft Dysfunction After Heart Transplantation: Will Achilles Ever Overtake the Tortoise? J. Card. Fail. (IF 6.0) Pub Date : 2024-03-07 MELANA YUZEFPOLSKAYA MD, PAOLO C. COLOMBO MD
-
Cardiogenic Shock Intravascular Cooling Trial (CHILL-SHOCK) J. Card. Fail. (IF 6.0) Pub Date : 2024-03-06 NIKHIL GUPTA MD, ROHAN J. KALATHIYA MD, NIKHIL SINGH MD, NADEEM BANDEALY MD, MARYAM NEYESTANAK PhD, STEPHANIE BESSER MS, CYNTHIA AREVALO MA, JANET FRIANT APN, JOHN E.A. BLAIR MD, SANDEEP NATHAN MD, ATMAN P. SHAH MD, JONATHAN PAUL MD
-
Poor Medication Access as a Driver of Excess Heart-Failure Readmissions Among Patients Living in Economically Deprived Neighborhoods J. Card. Fail. (IF 6.0) Pub Date : 2024-03-06 APOORVA GANGAVELLI MD MSC, ZIHAO LIU MPH, JEFFREY WANG MD, ALEXIS OKOH MD, REBECCA S. STEINBERG MD MSC, KRISHAN PATEL MD, SHIVANI A. PATEL PHD MPH, NEAL W. DICKERT MD PHD, ALANNA A. MORRIS MD MSC
-
Temporal Outcomes of Patients Diagnosed With Transthyretin Cardiac Amyloidosis J. Card. Fail. (IF 6.0) Pub Date : 2024-03-06 NICHOLAS CHAN MD MS, SERGIO TERUYA MD MS, ALFONSINA MIRABAL MD, ARIEL Y. WEINSAFT, JEFFENY DE LOS Santos MD MHA, SAMANTHA GUADALUPE MHA, MASSIEL JIMENEZ MD, CARLOS RODRIGUEZ MD, STEPHEN HELMKE RDCS MPH, MARGARET CUOMO MSN FNP-C, DIA SMILEY DO, MATHEW S. MAURER MD
-
Wearable Sensors to Monitor Physical Activity in Heart Failure Clinical Trials: State-of-the-Art Review J. Card. Fail. (IF 6.0) Pub Date : 2024-03-05 RUBEN BUENDIA PhD, MARTIN KARPEFORS PhD, FOLKE FOLKVALJON, ROBERT HUNTER, HENRIK SILLEN, LONG LUU PhD, KIERAN DOCHERTY MD, MARTIN R COWIE MD PhD
-
Leveraging the Full Potential of Wearable Devices in Cardiomyopathies J. Card. Fail. (IF 6.0) Pub Date : 2024-03-05 Evangelos K. Oikonomou MD DPhil, Rohan Khera MD MS
-
Personalized Pacing for HFpEF: myPACE J. Card. Fail. (IF 6.0) Pub Date : 2024-03-05 Markus Meyer MD PhD
-
Unmasking HFpEF With Artificial Intelligence: A Disruptive Opportunity for Disease Detection J. Card. Fail. (IF 6.0) Pub Date : 2024-03-05 AMOGH KARNIK MD MSc, MADELINE JANKOWSKI RDCS, AKHIL NARANG MD
-
The Ideal Heart Rate for Heart Failure and Ejection Fraction > 40%: Both Myth and Magic? J. Card. Fail. (IF 6.0) Pub Date : 2024-03-04 MILTON PACKER MD
-
Going With the Flow: Device Therapy for Heart Failure Complicated by Cardiorenal Syndrome J. Card. Fail. (IF 6.0) Pub Date : 2024-03-04 LINDSEY AURORA MD, GILLIAN GRAFTON DO, JENNIFER COWGER MD MS
-
Obesity and Heart Failure: A New Era Begins J. Card. Fail. (IF 6.0) Pub Date : 2024-03-04 Barry A. Borlaug MD, Tammy L. Kindel MD PhD
-
Early Experience With Devices That Reduce Kidney Vascular Afterload From the Veins J. Card. Fail. (IF 6.0) Pub Date : 2024-03-04 ALEXANDER M. SPRING MD, ENKLAJD MARSELA MD, ULRICH P. JORDE MD
-
Contemporary Diuretic Therapies for Acute Heart Failure: Time for a Desalination-Guided Approach? J. Card. Fail. (IF 6.0) Pub Date : 2024-03-04 WILFRIED MULLENS MD PhD, PIETER MARTENS MD PhD
-
The Effectiveness of Lifestyle Interventions in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis J. Card. Fail. (IF 6.0) Pub Date : 2024-02-29 GRACE W.M. WALTERS PhD, JIAN L. YEO MD, JOANNA M. BILAK MBBS, CORAL PEPPER, GAURAV S. GULSIN MD PhD, SUZANNE C. FREEMAN PhD, LAURA J. GRAY PhD, GERRY P. McCANN MD PhD, EMER M. BRADY PhD
-
The Future of Durable Mechanical Circulatory Support: Emerging Technological Innovations and Considerations to Enable Evolution of the Field J. Card. Fail. (IF 6.0) Pub Date : 2024-02-29 Seraina A. Dual PhD, Jennifer Cowger MD MS, Ellen Roche PhD, Aditi Nayak MD MS
-
Patient Focus: A Prescription to Move. An Explanation of The Effectiveness of Lifestyle Interventions in Heart Failure With Preserved Ejection Fraction: A Systematic Review and Network Meta-Analysis J. Card. Fail. (IF 6.0) Pub Date : 2024-02-27 ANAS JAWAID MD, JENNIFER T. THIBODEAU MD MSCS
In this issue of the Journal of Cardiac Failure, Dr. Grace Walters and colleagues look at which lifestyle interventions in the treatment of Heart Failure with Preserved Ejection Fraction (HFpEF) can best improve exercise tolerance, functional capacity, and overall quality of life ().
-
Settling the IRONy of Anemia in Heart Failure: Current Evidence and Future Directions J. Card. Fail. (IF 6.0) Pub Date : 2024-02-23 Adamantios Tsangaris MD, Andrew P. Ambrosy MD, Michael Tschida MS, Tamas Alexy MD
-
Safety Indicators in the STRONG-HF Trial From a Methodological Perspective J. Card. Fail. (IF 6.0) Pub Date : 2024-02-21 Xavier Rossello MD PhD
-
Modes of Death in Patients with Cardiogenic Shock in the Cardiac Intensive Care Unit: A Report from the Critical Care Cardiology Trials Network J. Card. Fail. (IF 6.0) Pub Date : 2024-02-21 DAVID D. BERG MD MPH, SACHIT SINGAL MD, MICHAEL PALAZZOLO MS, VIVIAN M. BAIRD-ZARS MPH, FADEL BOFARRAG MD MPH, ERIN A. BOHULA MD DPhil, SUNIT-PREET CHAUDHRY MD, MARK W. DODSON MD PhD, DUSTIN HILLERSON MD, PATRICK R. LAWLER MD MPH, SHUANGBO LIU MD, CONNOR G. O'BRIEN MD, BARBARA A. PISANI MD, LEKHA RACHARLA DO, ROBERT O. ROSWELL MD, KEVIN S. SHAH MD, MICHAEL A. SOLOMON MD MBA, LAKSHMI SRIDHARAN MD, ANDREA
There are limited data on how patients with cardiogenic shock (CS) die. The Critical Care Cardiology Trials Network is a research network of cardiac intensive care units coordinated by the Thrombolysis In Myocardial Infarction (TIMI) Study Group (Boston, MA). Using standardized definitions, site investigators classified direct modes of in-hospital death for CS admissions (October 2021 to September
-
Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2is) Following FDA Approval for Heart Failure With Preserved and Mildly Reduced Ejection Fraction J. Card. Fail. (IF 6.0) Pub Date : 2024-02-16 Trejeeve Martyn MD MSC, Joshua Saef MD MSC, Agam Bansal MD, Kathryn A. Martinez PhD, Hunter Block-Beach BS, Jessica Hohman MD MSC, Samir R. Kapadia MD, Milind Y. Desai MD MBA, Jerry D. Estep MD, Nancy M. Albert PhD, Randall C. Starling MD MPh, W.H. Wilson Tang MD
-
Outcomes of Patients With Cardiogenic Shock in Hub and Spoke Centers: The importance of Protocol Standardization at a Network Level J. Card. Fail. (IF 6.0) Pub Date : 2024-02-16 Carlos L. Alviar MD, Sylvie Hall PharmD, Alexandre Mebazaa MD PhD
-
Genetic Interleukin-6 Receptor Variant Is Not Associated With Rejection and Mortality After Heart Transplantation J. Card. Fail. (IF 6.0) Pub Date : 2024-02-16 KAUSHIK AMANCHERLA MD, KELLY H. SCHLENDORF MD MHS, CAITLYN VLASSCHAERT MD MSc, BRANDON D. LOWERY, QUINN S. WELLS MD MSCI, SARAH B. SEE PhD, EMMANUEL ZORN PhD, PAOLO C. COLOMBO MD, MUREDACH P. REILLY MBBCh MSCE, JOANN LINDENFELD MD, NIR URIEL MD MSc, RAVI V. SHAH MD, JANE E. FREEDMAN MD, JAVID MOSLEHI MD, ALEX G. BICK MD PhD, KEVIN CLERKIN MD MSc
-
Low levels of selenoprotein P associate with cognitive impairment in patients hospitalized for heart failure J. Card. Fail. (IF 6.0) Pub Date : 2024-02-15 Amra Jujić, John Molvin, Erik D. Nilsson, Hannes Holm Isholt, Anna Dieden, Johan Korduner, Amir Zaghi, Zainu Nezami, Andreas Bergmann, Lutz Schomburg, Martin Magnusson
[Display omitted]
-
The Growing Tools in the Toolbox for Heart Transplantation J. Card. Fail. (IF 6.0) Pub Date : 2024-02-15 GENE KIM MD, MARIA GIOVANNA TRIVIERI MD PhD
-
-
-
A Board of Our Own: The New American Board for Cardiovascular Medicine J. Card. Fail. (IF 6.0) Pub Date : 2024-02-13 JAMES C. FANG
-
The Heart as a Reminder for Oneness J. Card. Fail. (IF 6.0) Pub Date : 2024-02-13 ANURADHA LALA, MEREDITH T. HURT, ROBERT J. MENTZ
-
-
Malnutrition and Sarcopenia as Reasons for Caution with GLP-1 Receptor Agonist Use in HFpEF J. Card. Fail. (IF 6.0) Pub Date : 2024-02-01 ELISSA DRIGGIN MD MS, PARAG GOYAL MD MSC
-
Patient Focus: Sodium-Glucose Cotransporter-2 Inhibitor Rates for Patients with Heart Failure in the Veterans Affairs Health System. We Need to Move the Needle! An explanation of “Uptake of Sodium-Glucose Cotransporter-2 Inhibitors in Hospitalized Patients with Heart Failure: Insights from the Veterans Affairs Healthcare System” J. Card. Fail. (IF 6.0) Pub Date : 2024-01-27 Nicholas S. Hendren, Jennifer T. Thibodeau
Abstract not available
-
Uptake of sodium-glucose cotransporter-2 inhibitors in hospitalized patients with heart failure: insights from the veterans affairs healthcare system J. Card. Fail. (IF 6.0) Pub Date : 2024-01-26 Anubodh S. Varshney, Jamie Calma, Neil M. Kalwani, Stephanie Hsiao, Karim Sallam, Fang Cao, Natasha Din, Jessica Schirmer, Ankeet S. Bhatt, Andrew P. Ambrosy, Paul Heidenreich, Alexander T. Sandhu
Background The use of sodium-glucose cotransporter-2 inhibitor (SGLT2i) in Veteran Affairs (VA) patients hospitalized with heart failure (HF) has not been previously reported. Methods VA electronic health record data were used to identify patients hospitalized for HF (primary or secondary diagnosis) from 01/2019-11/2022. Patients with SGLT2i allergy, advanced/end-stage chronic kidney disease (CKD)
-
A Single Center Analysis of Palliative Care Clinician Contact Following Declination from Advanced Heart Failure Therapy J. Card. Fail. (IF 6.0) Pub Date : 2024-01-26 Kolby Johnson, Leigh Vaughan, Jennifer Dulin, Elizabeth Higgins, Abigail Southard
Abstract not available
-
Advanced Heart Failure and Transplant Cardiology as a New Subspecialty in Latin America: Challenges and Opportunities Based on a Brazilian Survey Study J. Card. Fail. (IF 6.0) Pub Date : 2024-01-22 Rafaela Vebber Bisol, Nadine Clausell, Jefferson L. Vieira, Fernando Bacal, Renato D. Lopes, Livia Adams Goldraich
Abstract not available
-
With Great Data Come Great Responsibilities: The Cardiac Amyloidosis Registry Study J. Card. Fail. (IF 6.0) Pub Date : 2024-01-18 Jennifer Maning, Sanjiv J. Shah, Ravi B. Patel
Abstract not available
-
Blood pressure response and symptoms during active standing test among hospitalized and outpatients with heart failure: results from the GRAVITY-HF prospective observational cohort study J. Card. Fail. (IF 6.0) Pub Date : 2024-01-17 Anzhela Soloveva, Darya Fedorova, Marat Fudim, Nadezhda Vinogradova, Alena Chemodanova, Anastasia Kozlova, Igor Fomin, Mariya Skuratova, Natalia Shneidmiller, Galina Golovina, Elena Kosmacheva, Ekaterina Gubareva, Marina Teterina, Elena Godunko, Anna Chesnikova, Igor Okunev, Vasily Kashtalap, Mariia Kuznetsova, Olga Dzhioeva, Kristina Kopeva, Svetlana Villevalde
-
Left Atrial Myopathy As Assessed On Echocardiography Is Predictive Of Atrial Fibrillation Recurrence After Coronary Artery Bypass Surgery J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Al-Ameen Oredegbe, Jeanwoo Yoo, Kyle Miller, Hafiza Waqar, John Tremblay, Zachary Kimball, George Tawfellos, Evan Adelstein, Mikhail Torosoff
Background Atrial fibrillation (AF) and atrial flutter (AFL) are common after coronary artery bypass (CABG) surgery and are associated with significant morbidity. Assessed with echocardiogram left atrial function has been shown in various studies to be a marker of cardiovascular risk. Effects of left atrial size and function on post-CABG acute and recurrent atrial fibrillation were not well investigated
-
A Reason to be Positive: Early Cardiac Allograft Vasculopathy and Acute Rejection in Recipients of HCV+ Donor Hearts J. Card. Fail. (IF 6.0) Pub Date : 2024-01-11 Laura DiChiacchio, Andrew R Higgins
Abstract not available
-
Relationship Between Healthcare Team Segregation & Receipt Of Care By A Cardiologist According To Patient Race J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Janina Quintero Bisono, Delancee Trabue, Ryan Yee, Shannon Knapp, Francesca Williamson, Adedoyin Johnson, Stephen Watty, Natalie Pool, Megan Hebdon, Wanda Moore, Ekoh Yankah, Nneamaka Ezema, Nia Kimbrough, Jhonnie Washington, Karen Lightbourne, Brownsyne Tucker Edmonds, Quinn Capers, David Brown, Denee Johnson, Jalynn Evans, Khadijah Breathett
Background Segregation index (SI) has been used to measure the degree of segregation between racial groups within specific geographic areas and has been associated with worse health outcomes. However, the relationship between SI within healthcare teams (degree of heterogeneity between teams that care for Black patients versus White patients, also called dissimilarity index) and cardiovascular care
-
Revealing The Enigma Of Cardiac Sarcoidosis: The Crucial Significance Of Advanced Imaging Modalities- A Case Report J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Resha Khanal, Sharad Oli, Luis Afonso, Lobelia Samavati
Background Cardiac sarcoidosis (CS) can present with various symptoms including heart failure, arrhythmias or sudden cardiac death. Due to this diverse presentation, the management can be challenging. We present a case of CS illuminating the significance of multimodality imaging techniques. Case 26-year male with biopsy proven pulmonary sarcoidosis presented with palpitation and lightheadedness. EKG
-
Weight Loss Management By A Pharmacist To Overcome Obesity As A Barrier To Surgical Advanced Heart Failure Interventions J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Amy D. Brewster, Samantha Bacon, Dmitry Yaranov
Introduction The prevalence of obesity has risen significantly in the Unites States since 2000, from 30.5% to 41.9% with a rise in severe obesity as well. Patients with obesity struggle with a variety of comorbid conditions including heart disease. Unfortunately, obesity places candidates for advanced heart failure (AHF) therapies at higher risk for complications and post intervention mortality. AACE/ACE
-
Outpatient Navigation Increases Enrollment In Serious Illness Services For Outpatients With Chronic Heart Failure J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Joy Duer, Juhi Saxena, Hongmei Yang, Emily Bowers, Bridget Hiller, John Barkley, Priyesh Patel
Intro Heart failure is a common and costly medical illness with poor prognosis, with as low as 25% survival rate at 5 years post-index hospitalization. Many serious illness services (SIS) such as clinic-based palliative care, home based palliative care, hospice, and nurse care management have been developed to improve quality of life and reduce acute care utilization. However, these services remain
-
Impact Of Disease Management Interventions On Heart Failure Preserved Ejection Fraction In An Acute Setting J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Susan Bionat, Miriam delaflor Santa Ana
Background Heart failure with preserved EF ( HFpEF) is a condition common in the older population related to multiple co morbidities. According to “The Get With The Guidelines-Heart Failure “registry which was linked to Medicare administrative data (2006 - 2014) data that hospitalized patients with HFpEFa are ≥65 years of age. The final cohort included 53,065 patients with HFpEF and the overall 30-day
-
Patients With Amyloidosis Undergoing Transcatheter Edge-to-edge Repair Have Greater Risk Of Mortality And Higher Resource Utilization, Nation-wide Study J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Leonid Khokhlov, Fatima Hussain, Mehnaaz Ali, Angel Mena, Amr Aboelnasr, Sila Mateo-Faxas, Amin Eshghabadi, Mohamad Hijazi, Kenan Rahima, Sindhu Kishore, Kamal Shemisa, Mohammed Al-Amoodi
Background Transcatheter edge-to-edge repair (TEER) is a minimally invasive approach in the treatment of primary mitral regurgitation. Amyloidosis is a rare condition caused by misfolded protein fibrils deposition in the extracellular space. There is limited evidence of clinical outcomes in patients hospitalized for TEER and affected by amyloidosis. Hence, we sought to investigate this population.
-
Impact Of Covid-19 Pandemic And Expansion Of Telemedicine On Palliative Care Utilization Among Patients Admitted With Heart Failure J. Card. Fail. (IF 6.0) Pub Date : 2024-01-09 Aleesha Kainat, Bradley Very, Ahmet Sezer, Floyd Thoma, Gavin Hickey
Introduction The 2022 ACC/AHA/HFSA guidelines recommend integration of palliative care (PC) in heart failure (HF) management. Despite these recommendations, palliative care (PC) utilization remains suboptimal. It remains unclear how the evolution of telemedicine during the COVID-19 pandemic impacted PC delivery for the HF population. We sought to evaluate trends in telemedicine and in-person PC visits